Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Paper
Log in
Sign up
Paper
0
Paper
Conversation
Grants
Reviews
Document
Download
Flag content
0
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
Biochemistry
Oncology
Immunology
Show More
Authors
Ryoichi Miura
,
Atsushi Ono
Hikaru Nakahara
,
Yuki Shirane
,
Kenji Yamaoka
,
Yasutoshi Fujii
,
Shinsuke Uchikawa
,
Hatsue Fujino
,
Eisuke Murakami
,
Tomokazu Kawaoka
,
Daiki Miki
,
Masataka Tsuge
,
Takeshi Kishi
,
Waka Ohishi
,
Naoya Sakamoto
,
Koji Arihiro
,
C. Hayes
+15 authors
,
Shiro Oka
Journal
Journal of Gastroenterology
Published
Dec 9, 2024
DOI
10.1007/s00535-024-02185-w
Show more
Save
Tip
Document
Download
Flag content
0
Tip
Save
Document
Download
Flag content
Paper
Conversation
Grants
Reviews
Post
Best
Best
Newest
Upvoted
Start the discussion.
This paper has not yet been discussed.